Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Item
http://www.wikidata.org/entity/Q38909786
Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and MethotrexateMolecular basis of targeted therapy in T/NK-cell lymphoma/leukemia: A comprehensive genomic and immunohistochemical analysis of a panel of 33 cell linesIKK inhibition increases bortezomib effectiveness in ovarian cancer.Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma.Genetics of Cutaneous T Cell Lymphoma: From Bench to Bedside.Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells.DMF: a promising therapeutic option in CTCL.The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1.CRIg, a tissue-resident macrophage specific immune checkpoint molecule, promotes immunological tolerance in NOD mice, via a dual role in effector and regulatory T cells.Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs.Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5iAn Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs
P2860

Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.

Item
http://www.wikidata.org/entity/Q38909786
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Bortezomib inhibits expression ...... taneous T cell lymphoma cells.
@en
type
label
Bortezomib inhibits expression ...... taneous T cell lymphoma cells.
@en
prefLabel
Bortezomib inhibits expression ...... taneous T cell lymphoma cells.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Bortezomib inhibits expression ...... taneous T cell lymphoma cells.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932